Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516199 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Novel Therapeutic Targets for Antiarrhythmic Drugs

John Wiley and Sons Ltd, Jan 2010, Pages: 586


  Description  
   Table of Contents   
   Author   
    
    
     
  Enquire before Buying   
  Send to a Friend   

Profiles potential treatment approaches for cardiac arrhythmias

Cardiac arrhythmias of ventricular origin are responsible for the deaths of nearly half a million Americans each year while atrial fibrillation accounts for about 2.3 million cases per year, a rate that is projected to increase 2.5 fold over the next half century. Effectively managing these cardiac rhythm disorders remains a major challenge for both caregivers and the pharmaceutical industry. Filling a gap in the current literature, Novel Therapeutic

Targets for Antiarrhythmic Drugs presents the latest treatments for cardiac arrhythmias alongside comprehensive presentations of basic cardiac physiology and pharmacology.

Written by leading experts in their research areas, this invaluable resource offers both practitioners and researchers a one-stop guide that brings together previously dispersed information. The text consists of four sections:

- Section One comprehensively reviews basic cardiac electrophysiology, the mechanisms responsible for arrhythmias in the setting of ischemia, and basic pharmacology of antiarrhythmic drugs.
- Section Two addresses safety pharmacology, including the concept of 'repolarization reserve,' safety challenges, and regulatory issues for the development of novel antiarrhythmic drugs.
- Section Three describes several novel pharmacological targets for antiarrhythmic drugs, including both ion channel and non-ion channel targets.
- Section Four describes promising non-pharmacological antiarrhythmic interventions including selective cardiac neural disruption or nerve stimulation, aerobic exercise training, and diet (omega-3 fatty acids).

Offering an unparalleled look at the current state and future direction of cardiac arrhythmia treatment, Novel Therapeutic Targets for Antiarrhythmic Drugs provides an important resource to advanced students, working researchers, and busy professionals alike.


Product samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought

Atrial Fibrillation: Emerging Drug Discovery Targets and Therapeutic Candidates

Cardiovascular Drug Delivery - Technologies, Markets and Companies

Problem Solving in Cardiology

Evidence-Based Cardiology, 3rd Edition

Pain Therapeutics - Drugs, Markets and Companies

Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies

Alzheimer Disease - New Drugs, Markets and Companies

Structure, Function and Modulation of Neuronal Voltage-Gated Ion Channels

Cardiovascular Problems in Emergency Medicine: A Discussion-based Review

Cardiac Rhythm Management Devices World Markets



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds